Astrological Analysis of PNAS Abstract on Month of Birth and Longevity – Video

Posted on by


Astrological Analysis of PNAS Abstract on Month of Birth and Longevity
On February 27, 2001 the Proceedings of the National Academy of Sciences of the United States of America (www.pnas.org) published an abstract titled "Lifespan depends on month of birth" by...

By: Michael Neely

See the rest here:
Astrological Analysis of PNAS Abstract on Month of Birth and Longevity - Video

Banned fountain of youth drug may be making a comeback

Posted on by

July 3, 2013 Despite it being more than 30 years since the "fountain of youth drug" Gerovital H3 was banned in the United States, it may be making a comeback. In an editorial published in this month's Journal of the American Geriatrics Society BUSM researcher Thomas Perls, MD, points out that a few U.S.-based anti-aging and longevity clinics have begun to advertise Gerovital H3 in pill form and as intravenous infusions despite the fact that the U.S. Food and Drug Administration (FDA) banned it in 1982.

Gerovital H3 is the dental anesthetic procaine hydrochloride (novocaine), yet in the 1950s, this drug was abused among Hollywood stars. According to Perls governmental bodies such as the FDA are relied upon to protect their citizens from drugs that do not do what they are claimed to do or are unsafe, yet in communist Romania, the opposite occurred with the state-sponsored marketing of Gerovital H3. In 1956, a paper titled "A new method for prophylaxis and treatment of aging with Novocain-eutrophic and rejuvenating effects" was published in the now discontinued journal Therapiewoche by Ana Aslan, director of the Geriatrics Institute of Bucharest. As a result the communist regime established an anti-aging resort and clinic for foreigners.

Perls explains that by the 1970s, the National Institute on Aging commissioned a thorough evaluation of the studies and claims surrounding Gerovital H3. "The conclusion of that work was that, except for a possible mild monoamine oxidase (MAO) inhibitor effect that would potentially ameliorate depression, there was no scientifically credible evidence supporting the claims that procaine hydrochloride is beneficial in treating age-related diseases or syndromes," said Perls, professor medicine at BUSM and director of the New England Centenarian and Supercentenarian Studies at Boston Medical Center. Perls points out that a plausible explanation for why some subjects might have experienced some improvements in health was that, in addition to receiving Gerovital H3, they were receiving other interventions such as exercise, stress reduction and healthy nutrition. "Thus, a glaring problem for the demonstration of any benefit associated with Gerovital H3 or similar compounds is the absence of any double-blind, placebo controlled trials demonstrating a significant improvement in the outcomes that anti-aging doctors and entrepreneurs claimed," he added.

Additional studies were later performed to further investigate a possible MAO inhibitory effect from procaine hydrochloride and any subsequent neurocognitive benefit but there was no evidence that procaine and its preparations could treat or preventing cognitive impairment or dementia.

"Gerovital H3 appears to have experienced a recent rebound in marketing and sales in the United States, primarily because of Internet-based marketing. A search for "Gerovital H3" on Google or Yahoo! results in more than 300,000 hits. Inquiring patients and the public need to be informed about the approved and unapproved uses of procaine hydrochloride and aware that there is no scientific evidence supporting any systemic health benefits or "anti-aging" effects of the drug," said Perls.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:

Story Source:

The above story is reprinted from materials provided by Boston University Medical Center, via EurekAlert!, a service of AAAS.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.

View original post here:
Banned fountain of youth drug may be making a comeback

The American Academy of Anti-Aging Medicine (A4M) Wrapped up an Advanced Endocrinology Workshop Sunday in Chicago

Posted on by

(PRWEB) July 03, 2013

The Fellowship in Anti-Aging and Regenerative Medicine (FAARM) Module 1C: Advanced Metabolic Endocrinology was held last weekend. The workshop featured speakers Gary Huber, DO; Director of the Fellowship Pam W. Smith, MD, MPH; Elizabeth Stuller, MD; and David Zava, PhD.

Lectures focused on breast health, estrogen metabolism and risk of developing breast cancer. A big focus of discussion was on womens health issues such as advanced therapies in dysmenorrhea, vulvodynia, cervical dysplasia, endometriosis, fibrocystic breast disease, dysfunctional uterine bleeding and amenorrhea. Also discussed was how memory and hormones affect heart health.

Main objectives of the module included how stress affects the body, how to treat adrenal dysfunction, hormone changes caused by aging, as well as estrogen, progesterone, testosterone, and DHEA; including the functions, excess, risks and benefits of these in the body.

In relation to this topic, The American Academy of Anti-Aging Medicine (A4M) will host a symposium on gut/brain and autoimmune disorders August 16-17 in Los Angeles.

The American Academy of Anti-Aging Medicine (A4M) offers exclusive membership to all medical professionals where they gain access to over two-decades of established medical expertise. We are also dedicated to educating physicians and scientists and are proud to be in our 21st year of providing first-class continuing education conferences on anti-aging issues, regenerative and functional medicine. To further demonstrate our commitment to the future of medicine, the shared responsibility for patient outcomes and transforming health education through innovation, we offer Board Certifications and Fellowship Training Programs in various disciplines ranging from anti-aging, regenerative and functional medicine to such disciplines as aesthetic medicine, skin cancer and stem cell therapy, in order to lead the industry by establishing best practice standards in these areas.

See original here:
The American Academy of Anti-Aging Medicine (A4M) Wrapped up an Advanced Endocrinology Workshop Sunday in Chicago

Casa Dorada Los Cabos Nominated as Mexico and Central America’s Leading Spa Resort at World Travel Awards 2013

Posted on by

Casa Dorada Los Cabos Nominated as Mexico and Central Americas Leading Spa Resort at World Travel Awards 2013

This year, World Travel Awards (WTA) is celebrating a landmark 20th year as the Oscars of the Travel Industry. In the Central & South American awards, travel, tourism and hospitality companies from 13 countries, including Mexico, will compete for the prestigious top accolades culminating in a glittering Gala Presentation Ceremony in Lima, Peru. The honorable recipients of a WTA have undergone rigorous independent examination, proven their excellence and have raised industry standards.

Casa Dorada can include this World Travel Award 2013 nomination among its many accolades. The Resort has previously been nominated as a World Travel Awards finalist for Mexico & Central Americas Leading Luxury Resort in 2010. It was also ranked #5 as top Family Hotel and #10 among Mexicos Top Resorts at Travel + Leisures Worlds Best Awards 2011.

About Casa Dorada With an incomparable location on Medano Beach--the best swimmable beach of Cabo, Casa Dorada is just steps away from world-class shopping, dining, entertainment, and the marina. As a member of Preferred Hotels & Resorts, a collection of the worlds finest independent luxury hotels, Casa Dorada Los Cabos brings the upscale service and family-friendly features to the Cabo San Lucas oceanfront. The Resort grants visitors a more convenient, yet equally spectacular, alternative to the more remote hotel zone of the Tourist Corridor. Boasting unobstructed vistas of Lands End and the famous Arch, Casa Dorada is just 30 minutes away from Los Cabos International Airport. All of the 185 spacious one, two, and three-bedroom suites and penthouses, open up to Los Cabos most dazzling ocean view, while the luminous and contemporary interiors ensure your comfort and satisfaction.

http://www.casadorada.com

Read more here:

Casa Dorada Los Cabos Nominated as Mexico and Central America’s Leading Spa Resort at World Travel Awards 2013